Fig 3. Analysis on the proportion of patients with no evidence of disease activity at 2-years included in the randomized clinical trials of Natalizumab or Fingolimod.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.